A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 ...

CHICAGO — ­New clinical trial results on the diabetes and obesity drug tirzepatide have doctors buzzing about its potential to treat heart failure, keep weight off and prevent type 2 diabetes. One of ...

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals. Weight ...

Please provide your email address to receive an email when new articles are posted on . New trial tested sacubitril/valsartan vs. placebo for preventing heart damage related to anthracycline ...

Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...

Heart health remains a complex balancing act between genetics, lifestyle, and medical treatments. While many medications save lives, certain drugs can silently strain the heart’s pumping ability, ...

How would you summarize your study for a lay audience? Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified ...